Skip to content

Drug interactions

Erythromycin + Larotrectinib

Severity: Moderate

Erythromycin and Larotrectinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erythromycin may increase larotrectinib plasma concentrations because larotrectinib is a CYP3A4 substrate. This could increase toxicities such as neurotoxicity, transaminase elevation and myelosuppression.

What this interaction means in plain words

Erythromycin and Larotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erythromycin belongs to Anti Bacterial; Larotrectinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Erythromycin inhibits CYP3A4, reducing larotrectinib metabolism.

What to do

Where possible, choose an alternative antibiotic that does not inhibit CYP3A4. If coadministered, monitor for larotrectinib adverse effects and liver enzymes.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erythromycin and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erythromycin with Larotrectinib?

MediHelp rates the interaction as moderate. Erythromycin and Larotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erythromycin may increase larotrectinib plasma concentrations because larotrectinib is a CYP3A4 substrate. This could increase toxicities such as neurotoxicity, transaminase elevation and myelosuppression.

How serious is the interaction between Erythromycin and Larotrectinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, choose an alternative antibiotic that does not inhibit CYP3A4. If coadministered, monitor for larotrectinib adverse effects and liver enzymes.

What other medicines interact with Erythromycin?

MediHelp also lists interactions of Erythromycin with, for example, Conivaptan, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Erythromycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in